{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:13:05Z","timestamp":1776744785887,"version":"3.51.2"},"reference-count":31,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2023,11,2]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To systematically review and meta-analyse the effect of late surfactant administration versus placebo in reducing the incidence of death or bronchopulmonary dysplasia (BPD) in preterm infants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>PubMed, EMBASE, CINAHL and Cochrane CENTRAL were searched until 30 May 2023, for randomised controlled trials (RCTs) comparing administration of surfactant after 48\u2009hours of age versus placebo in preterm ventilator-dependent neonates. The primary outcome was incidence of death or BPD at 36 weeks\u2019 postmenstrual age (PMA). Secondary outcomes included incidence of BPD at 36 weeks PMA, pre-discharge mortality, use of postnatal steroids, post-discharge respiratory support, treatment with steroids or hospitalisation prior to 1-year corrected age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Pooled analyses of four RCTs (N=850) showed no statistically significant difference between groups in the incidence of death or BPD at 36 weeks\u2019 PMA (relative risk (RR) 0.99; 95% CI 0.90 to 1.10; Grades of Recommendation, Assessment, Development and Evaluation (GRADE): moderate). Late surfactant administration significantly decreased the need for post-discharge respiratory support prior to 1-year corrected age (two RCTs; N=522; RR 0.72; 95%\u2009CI 0.59 to 0.89; GRADE: low). Other secondary outcomes did not differ significantly between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Administration of late surfactant does not improve the rates of death or BPD at 36 weeks when administered to preterm infants with prolonged respiratory insufficiency. Additional adequately powered trials are needed to establish the efficacy of late surfactant therapy in preterm infants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42023432463.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2023-326333","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:20:20Z","timestamp":1700745620000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Late surfactant administration after 48 hours of age in preterm neonates with respiratory insufficiency: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2256-8572","authenticated-orcid":false,"given":"Gonzalo","family":"Sol\u00eds-Garc\u00eda","sequence":"first","affiliation":[{"name":"Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Neonatology, Hospital Universitario Doce de Octubre, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Elias","sequence":"additional","affiliation":[{"name":"Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dunn","sequence":"additional","affiliation":[{"name":"Neonatology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonny","family":"Jasani","sequence":"additional","affiliation":[{"name":"Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"2025090221503408000_109.3.301.1","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221503408000_109.3.301.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10708"},{"key":"2025090221503408000_109.3.301.3","doi-asserted-by":"crossref","unstructured":"Seger N , Soll R . Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009:CD007836. doi:10.1002\/14651858.CD007836","DOI":"10.1002\/14651858.CD007836"},{"key":"2025090221503408000_109.3.301.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10244"},{"key":"2025090221503408000_109.3.301.5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa1605566","article-title":"Survival and neurodevelopmental outcomes among periviable infants","volume":"376","author":"Younge","year":"2017","journal-title":"N Engl J Med"},{"key":"2025090221503408000_109.3.301.6","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ppul.25381","article-title":"Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia","volume":"56","author":"DeMauro","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2025090221503408000_109.3.301.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054065"},{"key":"2025090221503408000_109.3.301.8","article-title":"Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants","volume":"2016","author":"Darlow","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221503408000_109.3.301.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00202-6"},{"key":"2025090221503408000_109.3.301.10","doi-asserted-by":"crossref","unstructured":"Doyle LW , Ehrenkranz RA , Halliday HL . Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014:CD001145. doi:10.1002\/14651858.CD001145.pub3","DOI":"10.1002\/14651858.CD001145.pub3"},{"key":"2025090221503408000_109.3.301.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1973"},{"key":"2025090221503408000_109.3.301.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0861OC"},{"key":"2025090221503408000_109.3.301.13","doi-asserted-by":"publisher","DOI":"10.1053\/siny.2002.0129"},{"key":"2025090221503408000_109.3.301.14","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000145565.45490.D9"},{"key":"2025090221503408000_109.3.301.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0095"},{"key":"2025090221503408000_109.3.301.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211533"},{"key":"2025090221503408000_109.3.301.17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211909"},{"key":"2025090221503408000_109.3.301.18","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/s41372-021-01142-2","article-title":"Comparative efficacy and safety of late surfactant preparations: a retrospective study","volume":"41","author":"Lane","year":"2021","journal-title":"J Perinatol"},{"key":"2025090221503408000_109.3.301.19","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221503408000_109.3.301.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025090221503408000_109.3.301.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201812-2348OC"},{"key":"2025090221503408000_109.3.301.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.01.012"},{"key":"2025090221503408000_109.3.301.23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2680"},{"key":"2025090221503408000_109.3.301.24","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2012.136"},{"key":"2025090221503408000_109.3.301.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.09.031"},{"key":"2025090221503408000_109.3.301.26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamapediatrics.2015.4617","article-title":"Late surfactant administration in very preterm neonates with prolonged respiratory distress and pulmonary outcome at 1 year of age. A randomized clinical trial","volume":"170","author":"Hasco\u00ebt","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2025090221503408000_109.3.301.27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpeds.2016.12.059","article-title":"The randomized, controlled trial of late surfactant: effects on respiratory outcomes at 1-year corrected age","volume":"183","author":"Keller","year":"2017","journal-title":"J Pediatr"},{"key":"2025090221503408000_109.3.301.28","article-title":"Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome","volume":"11","author":"Bahadue","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221503408000_109.3.301.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102097","article-title":"Clinical decision thresholds for surfactant administration in preterm infants: a systematic review and network meta-analysis","volume":"62","author":"Ramaswamy","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025090221503408000_109.3.301.30","doi-asserted-by":"crossref","unstructured":"Patel P , Houck A , Fuentes D . n.d. Examining variations in surfactant administration (ENVISION): a neonatology insights pilot project. Children;8:261. doi:10.3390\/children8040261","DOI":"10.3390\/children8040261"},{"key":"2025090221503408000_109.3.301.31","first-page":"268","article-title":"Postsurfactant slump: early prediction of neonatal chronic lung disease","volume":"14","author":"Sobel","year":"1994","journal-title":"J Perinatol"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-326333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:50:44Z","timestamp":1756875044000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-326333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,18]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/archdischild-2023-326333"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-326333","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}